Slumping anaemia sales hit Kyowa Kirin's outlook
This article was originally published in Scrip
Executive Summary
Newly formed Kyowa Hakko Kirin has hauled back its net profit guidance for the first half and full year, citing lower than expected sales in its key pharmaceutical franchise.